Navigation Links
Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102
Date:7/22/2011

TOKYO, July 22, 2011 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President: Toru Usami) announced on July 22 the results of a randomized, Phase II clinical trial for the novel oral nucleoside antitumor agent TAS-102 under development by the company for metastatic colorectal cancer, at the 9th Annual Meeting of the Japanese Society of Medical Oncology held in Yokohama. (Abstract no. 10428)

The trial was a randomized, double-blind, placebo-controlled study with a primary outcome measure of overall survival involving 172 patients with refractory metastatic colorectal cancer who had received standard chemotherapy at least two or more regimens containing a fluoropyrimidine, irinotecan, and oxaliplatin. The results indicated that the TAS-102 significantly improved overall survival compared with the placebo (overall survival median: 9.0 months vs. 6.6 months) and significantly reduced the risk of mortality (HR=0.56, p=0.0011). Also, no instances of treatment-related mortality were reported. The most frequently reported adverse drug reaction with a CTCAE grade 3 or higher was neutropenia. Grade 3 or higher diarrhea, fatigue, nausea, and other adverse reactions were no more than 10%.

In light of these results, Taiho Pharmaceutical will proceed with global development of TAS-102 so that this drug can be offered as soon as possible to metastatic colorectal cancer patients who have exhausted proven treatment options and there remains a high unmet medical need.

About TAS-102:

TAS-102 is a novel oral nucleoside antitumor agent with a novel mechanism of action, composed of a mixture of Trifluorothymidine (FTD), which demonstrates antitumor effects through incorporation into DNA, and 5-chloro-6-(2-iminopyrrolidin-1-yl)-methyl-2,4(1H,3H)-pyrimidinedione hydrochloride (TPI), which inhibits the degradation of FTD. Phase I trials began in Japan in 2005, and the drug continues to be developed as a treatment for colorectal cancer refra
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... -- Concord Medical Services Holdings Limited ("Concord Medical" or ... specialty hospital management solution provider and operator of the ... China , today announced that on ... special cash dividend of US$0.30 per ordinary share (or ... outstanding ordinary shares. The total expense for the special ...
(Date:7/28/2014)... TOKYO , July 28, 2014  ImaginAb, Inc. ... Roger Crystal , MD as Vice President of Business ... Business Development Product Acquisition & Licensing team at G.E. ... business strategy and partnerships in the precision medicine space ... with biotechnology and pharmaceutical companies across the spectrum to ...
(Date:7/28/2014)... 2014   Cardioxyl Pharmaceuticals, Inc. announced today ... CXL-1427, a novel potential treatment for acute decompensated heart ... company has now initiated dosing of hospitalized patients with ... designed to further evaluate the drug,s safety and tolerability ... Phase I clinical trial evaluated the safety and tolerability ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2
... 15, 2011 Reportlinker.com announces that ... available in its catalogue: ... Facial Aesthetics and Medical Laser Devices ... The combined ...
... 2011 /PRNewswire-iReach/ -- URINOZINC® Prostate Formula ... (Photo:   http://photos.prnewswire.com/prnh/20110614/CG20097 ) The original, ... all corporate-owned GNC Live Well stores and at ... has more than 6,000 stores spread over 49 ...
Cached Medicine Technology:Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 2Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 3Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 4Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 5Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 6Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 7Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 8Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 9Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 10Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 11Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 12Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 13Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 14Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 15Reportlinker Adds European Markets for Cosmetic Surgery, Facial Aesthetics and Medical Laser Devices 2011 16Patented URINOZINC® Prostate Formula Now Available at GNC Stores 2Patented URINOZINC® Prostate Formula Now Available at GNC Stores 3
(Date:7/29/2014)... Lean and Lovely, an affordable and short program, claims ... wear a bikini in the near future. This has caught ... , “Our Lean and Lovely review shows that ... levels. Neither your age nor your body shape matters, which ... the beginning, you will achieve the results that you have ...
(Date:7/29/2014)... 29, 2014 Current Back2Basics long-term drug ... medication post foot surgery during his first six months of ... surgery – twice on one foot, once on the other– ... broke my foot a year ago and was prescribed drugs ... Jon by a friend from home who’d recently completed the ...
(Date:7/29/2014)... PeopleKeys today announced that they are launching ... to train and certify others in applied DISC behavioral ... , will be taught by PeopleKeys Master Coach Dan ... as a live Tele-course over the span of 10 ... Consultant Trainer course will use a combination of real-time ...
(Date:7/29/2014)... Maui, HI (PRWEB) July 29, 2014 Couples ... Seasons Resort Maui at Wailea. This September through November, ... of them free-- tailored to couples of all ages and ... and guests can take advantage of the Resort's popular ... $1,000 while the "twice yearly sale" is in full swing ...
(Date:7/29/2014)... 2014 In today’s world, a good night’s ... Snoring and sleep apnea (a medical problem where the airway ... bed partners of the rest they need to face their ... snores and 20 million people in the United States alone ... and treated; and of those treated, many cannot tolerate their ...
Breaking Medicine News(10 mins):Health News:Lean and Lovely: Review Examining Neghar Fonooni’s Program Released 2Health News:Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 3Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 2Health News:Four Seasons Resort Maui at Wailea Goes All Out to Give Couples Memorable Get-Away this Fall at Maui’s Luxury Resort 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... , Anti-Abortion Extremist Ejected After "Murder" ... night in northern Virginia, Representative James Moran and Governor Howard Dean ... by thousands of people. Anti-abortion extremist Randall Terry, the founder of ... be there to disrupt it by accusing President Obama of "killing ...
... reporting development of a new electronic sensor that shows promise ... tests now used to detect DNA. Such tests are ... new lab-on-a-chip test could lead to wider, more convenient use ... for the Sept. 2 issue of the Journal of ...
... Fla., Aug. 26 The only effective solution with proven performance to manage ... The RISS System(TM) removes the inorganic and organic sulfur based contaminants ... it is in Patent Pending status with the U.S. Office of Patents and ... www.RISS s y s tem . com ...
... , , LOS GATOS, Calif., Aug. 26 ... how she survived an airplane crash. Inspiring her audiences with her experience ... Bay area September/early October. , , She says, ... My life was full of stress, illness and failure. After major surgery ...
... , JERICHO, N.Y., Aug. 26 Optimum ... New York metropolitan area businesses, today announced that Medical ... in Long Island, has selected Optimum Lightpath as its ... Optimum Lightpath,s 100% fiber Ethernet connection, Medical Arts Radiology ...
... MORRIS PLAINS, N.J., Aug. 26 New entries in the eye ... eyes. , , "Eye irritation comes in ... including indoor and outdoor irritants and allergens like dust, pollen and ragweed, ... Brisco, O.D. "Since many people experience more than one symptom ...
Cached Medicine News:Health News:Randall Terry Removed By Police From Howard Dean Health Care Town Hall Meeting 2Health News:Proven Solution for Chinese Drywall is Now Available 2Health News:Australia's Contribution to Health and Ultra-longevity 2Health News:Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime, Anywhere Access to Patient Data and Communications 2Health News:Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime, Anywhere Access to Patient Data and Communications 3Health News:Breakthroughs in Eye Care Products Offer Fresh Approach for Soothing Eyes 2
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
... 48-capillary 3730 DNA Analyzer, upgradeable to 96 ... DNA analysis. , Higher optical sensitivity ... higher-quality data at a lower cost. , ... , Optimized polymers increase your productivity without ...
The Pipetman Large-Volume Kit includes two large-volume pipettes conveniently packaged with filters and tips at an exceptional price....
... an immunochromatography based one step in vitro ... Opiates and its metabolite in human urine,specimens. ... above a cut-off level of 300 ng/mL,can ... evaluated in the point of care location ...
Medicine Products: